Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 1,096 | 3,188 | 33 | 158 |
| Gross Profit | N/A | 1,096 | 3,188 | 33 | 158 |
| Operating Expenses | 24,593 | 24,862 | 27,778 | 24,768 | 24,365 |
| Operating Income | -24,593 | -23,766 | -24,590 | -24,735 | -24,207 |
| Other Income | 262 | 824 | 3,593 | 1,452 | 1,760 |
| Pre-tax Income | -24,331 | -22,942 | -20,997 | -23,283 | -22,447 |
| Income Tax | -80 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -24,251 | -22,942 | -20,997 | -23,283 | -22,447 |
| Net Income | $-24,251 | $-22,942 | $-20,997 | $-23,283 | $-22,447 |
| EPS Basic Total Ops | -4.98 | -5.28 | -5.00 | -5.50 | -6.00 |
| EPS Basic Continuous Ops | -4.98 | -5.28 | -4.84 | -5.54 | -5.70 |
| EPS Diluted Total Ops | -4.98 | -5.28 | -5.00 | -5.50 | -6.00 |
| EPS Diluted Continuous Ops | -4.98 | -5.28 | -4.84 | -5.54 | -5.70 |
| EPS Diluted Before Non-Recurring Items | -4.98 | -5.50 | -5.00 | -5.50 | -6.00 |
| EBITDA(a) | $-23,638 | $-22,718 | $-23,481 | $-23,704 | $-23,192 |